Takeda’s Edarbi approved as hypertension treatment
SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for hypertension, also known as high blood pressure, the agency said Friday.
The FDA approved Takeda’s Edarbi (azilsartan medoxomil).
“High blood pressure is often called the ‘silent killer’ because it usually has no symptoms until it causes damage to the body,” FDA Division of Cardiovascular and Renal Drug Products director Norman Stockbridge said. “High blood pressure remains inadequately controlled in many people diagnosed with the condition, so having a variety of treatment options is important.”
PCMA applauds Cuomo’s Medicaid proposal
WASHINGTON — In his 2011-2012 budget, New York governor Andrew Cuomo included a proposal to update New York’s Medicaid program. The announcement comes at the heels of New Jersey governor Chris Christie’s motion to modernize the state’s Medicaid plan.
Similarly to New Jersey’s plan, Cuomo said New York’s “Proposal to Redesign Medicaid” could save state taxpayers $350 million though 2015 by managing prescription drug benefits similarly to those in Medicare and private-sector programs.
The Pharmaceutical Care Management Association lauded Cuomo’s proposal, noting that New York’s Medicaid program could save $2.3 billion over the next decade by managing pharmacy benefits more like Medicare, Medicaid managed care plans and commercial-sector employer plans, citing a recent PCMA-commissioned study.
NACDS to host 2011 Supply Chain and Logistics Conference
ALEXANDRIA, Va. — The National Association of Chain Drug Stores is gearing up to host a conference designed for retail and manufacturer supply chain executives and logistics professionals.
The 2011 NACDS Supply Chain & Logistics Conference will be held at the Manchester Grand Hyatt in San Diego from March 13 to March 15.
The NACDS conference will cover a wide range of cutting-edge and emerging business topics, and will feature one-on-one business meetings and education and business programs.
For more information and to register, click here.